💨 Abstract
Agenus Inc., a Massachusetts-based biotechnology company, reported a second-quarter loss of $30 million, equating to $1 per share. The company's revenue for the quarter was $25.7 million. Shares were trading at $4.27, down from $5.09 a year ago.
Courtesy: WTOP Staff
Suggested
Schwarber hits his 42nd homer in a 4-run 8th inning as the Phillies rally past the Reds 4-1 -
Republicans, Democrats alike exhort Trump: Keep security pact with Australia and UK alive -
Nevada court apparently clears way for former Raiders coach Jon Gruden to sue NFL over emails -
¿Qué sucederá ahora que Trump tomó el control federal de la policía de Washington? -
Publican registros y documentos sobre tiroteo en Uvalde
49ers’ receiving group takes another hit with Jordan Watkins’ injury -
Arkansas authorities say additional employees disciplined at prison where ex-police chief escaped -
Stefanski’s timeline for announcing Browns starting QB remains uncertain -
Trump nominates conservative economist to head agency that compiles jobs, inflation data -
Correa plays 1st game in Houston since trade as Bregman visits for 1st time since joining Red Sox -